Jamie Lopez Bernal
About
Jamie Lopez Bernal is a scholar working on Infectious Diseases, Health and Molecular Biology.
According to data from OpenAlex, Jamie Lopez Bernal has authored 93 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 25 papers in Health and 20 papers in Molecular Biology. Recurrent topics in Jamie Lopez Bernal's work include SARS-CoV-2 and COVID-19 Research (36 papers), COVID-19 Clinical Research Studies (24 papers) and Vaccine Coverage and Hesitancy (21 papers). Jamie Lopez Bernal is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (36 papers), COVID-19 Clinical Research Studies (24 papers) and Vaccine Coverage and Hesitancy (21 papers). Jamie Lopez Bernal collaborates with scholars based in United Kingdom, Australia and United States. Jamie Lopez Bernal's co-authors include Antonio Gasparrini, Steven Cummins, Mary Ramsay, Nick Andrews, Julia Stowe, Maria Zambon, Elise Tessier, Kevin Brown, Charlotte Gower and Ruth Simmons and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Jamie Lopez Bernal
89 papers receiving 9.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jamie Lopez Bernal United Kingdom | 38 | 4.3k | 1.7k | 1.5k | 1.5k | 1.5k | 93 | 9.8k | ||
| Ran D. Balicer Israel | 42 | 3.4k 0.8× | 1.4k 0.8× | 679 0.5× | 1.3k 0.9× | 781 0.5× | 261 | 8.8k | ||
| Jue Liu China | 44 | 2.0k 0.5× | 1.0k 0.6× | 713 0.5× | 1.6k 1.1× | 1.0k 0.7× | 405 | 8.6k | ||
| Chris Robertson United Kingdom | 55 | 2.5k 0.6× | 901 0.5× | 1.1k 0.7× | 2.6k 1.8× | 682 0.5× | 272 | 11.7k | ||
| Elisabeth Mahase United Kingdom | 39 | 3.4k 0.8× | 984 0.6× | 624 0.4× | 527 0.4× | 909 0.6× | 878 | 8.0k | ||
| Alfonso J. Rodríguez‐Morales Colombia | 50 | 5.1k 1.2× | 600 0.3× | 1.3k 0.8× | 1.8k 1.2× | 1.3k 0.9× | 663 | 11.5k | ||
| Hongjie Yu China | 55 | 5.7k 1.3× | 1.6k 0.9× | 1.3k 0.9× | 4.7k 3.2× | 5.2k 3.6× | 436 | 16.3k | ||
| Tom Jefferson United Kingdom | 47 | 2.1k 0.5× | 1.4k 0.8× | 481 0.3× | 5.0k 3.4× | 1.1k 0.8× | 182 | 11.7k | ||
| Joseph T. Wu Hong Kong | 44 | 4.9k 1.1× | 799 0.5× | 644 0.4× | 3.0k 2.0× | 4.9k 3.4× | 153 | 11.1k | ||
| Niel Hens Belgium | 50 | 2.8k 0.7× | 1.4k 0.8× | 634 0.4× | 4.6k 3.1× | 4.0k 2.8× | 382 | 11.0k | ||
| Ben Y. Reis United States | 31 | 2.5k 0.6× | 1.3k 0.7× | 642 0.4× | 1.3k 0.8× | 800 0.6× | 71 | 5.9k |
Countries citing papers authored by Jamie Lopez Bernal
Since
Specialization
Citations
This map shows the geographic impact of Jamie Lopez Bernal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie Lopez Bernal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie Lopez Bernal more than expected).
Fields of papers citing papers by Jamie Lopez Bernal
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jamie Lopez Bernal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie Lopez Bernal. The network helps show where Jamie Lopez Bernal may publish in the future.
Co-authorship network of co-authors of Jamie Lopez Bernal
This figure shows the co-authorship network connecting the top 25 collaborators of Jamie Lopez Bernal. A scholar is included among the top collaborators of Jamie Lopez Bernal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie Lopez Bernal. Jamie Lopez Bernal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Elson, William H., Anna Forbes, Roger Morbey, et al.. (2025). A Systematic Review of the Markers of Severity in Acute Respiratory Infections to Inform Primary Care Surveillance. Influenza and Other Respiratory Viruses. 19(10). e70172–e70172.
2.
Whitaker, Heather, Freja Kirsebom, Catherine Quinot, et al.. (2025). Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation in England: 2022/2023 and 2023/2024 Seasons. Influenza and Other Respiratory Viruses. 19(12). e70194–e70194.
3.
Andrews, Nick, et al.. (2024). The impact of COVID-19 vaccine spring boosters on COVID-19 hospital admissions in England 2022/23. Journal of Infection. 89(3). 106221–106221.
4.
Quinot, Catherine, Freja Kirsebom, Nick Andrews, et al.. (2024). Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England. The Lancet Regional Health - Europe. 43. 100975–100975.
5.
Kirsebom, Freja, et al.. (2024). Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study. Journal of Infection. 89(1). 106177–106177.
6.
Kirsebom, Freja, Nick Andrews, Anna Mensah, et al.. (2024). Vaccine effectiveness against mild and severe covid-19 in pregnant individuals and their infants in England: test negative case-control study. SHILAP Revista de lepidopterología. 3(1). e000696–e000696.
7.
Kirsebom, Freja, Nick Andrews, Julia Stowe, et al.. (2024). Effectiveness of the Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation in England. EClinicalMedicine. 71. 102587–102587.
8.
Elson, William H., Cecilia Okusi, Rachel Byford, et al.. (2024). Validation of an acute respiratory infection phenotyping algorithm to support robust computerised medical record-based respiratory sentinel surveillance, England, 2023. Eurosurveillance. 29(35).
9.
Muhsen, Khitam, Pauline A. Waight, Freja Kirsebom, et al.. (2024). Association between COVID-19 Vaccination and SARS-CoV-2 Infection among Household Contacts of Infected Individuals: A Prospective Household Study in England. Vaccines. 12(2). 113–113.
10.
Sinnathamby, Mary, Fiona Warburton, Rebecca Guy, et al.. (2023). Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England. Open Forum Infectious Diseases. 10(6). ofad270–ofad270.
11.
Kirsebom, Freja, Nick Andrews, Julia Stowe, Mary Ramsay, & Jamie Lopez Bernal. (2023). Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study. The Lancet Infectious Diseases. 23(11). 1235–1243.
12.
Graham, Sophie, Elise Tessier, Julia Stowe, et al.. (2023). Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking. Nature Communications. 14(1). 3984–3984.
13.
Yates, Kathryn, et al.. (2023). Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study. Journal of the Royal Society of Medicine. 117(6). 202–211.
14.
Webster, Harriet, Tommy Nyberg, Mary Sinnathamby, et al.. (2022). Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England. Nature Communications. 13(1). 6053–6053.
15.
Stowe, Julia, Nick Andrews, Freja Kirsebom, Mary Ramsay, & Jamie Lopez Bernal. (2022). Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study. Nature Communications. 13(1). 5736–5736.
16.
Stowe, Julia, Elise Tessier, Hongxin Zhao, et al.. (2021). Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. International Journal of Epidemiology. 50(4). 1124–1133.
17.
Lusignan, Simon de, Ruby S. M. Tsang, Oluwafunmi Akinyemi, et al.. (2021). Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort Study. JMIR Public Health and Surveillance. 8(3). e25803–e25803.
18.
Jenkins, Misty R., Jesse A. Rudd-Schmidt, Jamie Lopez Bernal, et al.. (2015). Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. The Journal of Experimental Medicine. 212(3). 307–317.
19.
Bernal, Jamie Lopez, Olivia Susanto, Misty R. Jenkins, et al.. (2013). Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood. 121(14). 2659–2668.
20.
Bernal, Jamie Lopez, Misty R. Jenkins, Jesse A. Rudd-Schmidt, et al.. (2013). Rapid and Unidirectional Perforin Pore Delivery at the Cytotoxic Immune Synapse. The Journal of Immunology. 191(5). 2328–2334.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ran D. Balicer Breakdown of academic impact, for papers by Jue Liu Breakdown of academic impact, for papers by Chris Robertson Breakdown of academic impact, for papers by Elisabeth Mahase Breakdown of academic impact, for papers by Alfonso J. Rodríguez‐Morales Breakdown of academic impact, for papers by Hongjie Yu Breakdown of academic impact, for papers by Tom Jefferson Breakdown of academic impact, for papers by Joseph T. Wu Breakdown of academic impact, for papers by Niel Hens Breakdown of academic impact, for papers by Ben Y. Reis